Anaptysbio (ANAB) Interest & Investment Income (2016 - 2026)

Anaptysbio (ANAB) has 11 years of Interest & Investment Income data on file, last reported at $2.7 million in Q1 2026.

• Quarterly Interest & Investment Income fell 39.88% year-over-year to $2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (down 40.18% YoY) and the FY2025 annual result came in at $13.5 million, down 31.8% from the prior year.
• Interest & Investment Income grew to $2.7 million in Q1 2026, from $2.5 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $5.3 million in Q3 2024 to a low of $342000.0 in Q1 2022.
• A 5-year average of $3.7 million and a median of $4.4 million in 2025 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2022 — Interest & Investment Income surged 3434.38% — and 2025, when it slumped 52.35%.
• Tracing ANAB's Interest & Investment Income over 5 years: stood at $3.8 million in 2022, then rose by 27.12% to $4.9 million in 2023, then grew by 7.85% to $5.3 million in 2024, then tumbled by 52.35% to $2.5 million in 2025, then rose by 5.78% to $2.7 million in 2026.
• The last three Interest & Investment Income figures came in at $2.7 million (Q1 2026), $2.5 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.